Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
AMRX
$18.15
+5.10%
AMRX · Amneal Pharmaceuticals, Inc.
$18.15
+0.88 (+5.10%)
At close · Aug 14
Market Cap
$5.80B
Shares
319.35M
All earnings calls
Earnings call · FY2019 Q4
Amneal Pharmaceuticals, Inc. Q4 FY2019 Earnings Call
Amneal Pharmaceuticals, Inc. Q4 FY2019 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$397.33M
-20.1% YoY
Diluted EPS
-$0.23
Gross margin
27.7%
-11.2 pp YoY
Net income
-$64.90M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Feb 26, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 2, 2020 · complete as-filed document